Tyve patienter (50%) oplevede leukocytose, men hos alle disse patienter var WBC- tallet faldende eller havde normaliseret sig på tidspunktet for knoglemarvsremissionen, og cytotoksisk kemoterpi eller leukoferese var ikke påkrævet.
Twenty patients (50%) experienced leukocytosis; however, in all these patients, the WBC count was declining or had normalized by the time of bone marrow remission and cytotoxic chemotherapy or leukopheresis was not required.